Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine (C-C motif) ligand 21 (CCL21) is a small cytokine belonging to the CC chemokine family. It primarily functions as a homeostatic chemokine involved in immune cell trafficking, guiding CCR7-expressing leukocytes—such as naïve T cells and dendritic cells—to secondary lymphoid organs. CCL21 is essential for accumulation of developing thymocytes and critical for central self-tolerance establishment among T cells. It is constitutively produced in secondary lymphoid organs and expression increases during inflammation. CCL21 interacts with the receptor CCR7 triggering signaling pathways leading to cellular responses including migration/chemotaxis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine (C-C motif) ligand 21 (CCL21).